Lars Fruergaard Jørgensen is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations. From Wikipedia
Senators demand answers on why the diabetes and weight-loss drugs cost significantly more in the U.S. compared to other countries.
